Datopotamab deruxtecan is an antibody-coupled drug (ADC) consisting of a humanized, monoclonal antibody targeting human trophoblast cell surface glycoprotein antigen 2 (Trop2) conjugated to an innovative DNA topoisomerase I inhibitor (DXd) for use in studies related to non-small cell lung cancer (NSCLC).
Purity:
>99.0%
CAS Number:
[]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
